Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Investigation of Polyamine Metabolism and Homeostasis in Pancreatic Cancers.

Massaro C, Thomas J, Phanstiel Iv O.

Med Sci (Basel). 2017 Dec 7;5(4). pii: E32. doi: 10.3390/medsci5040032.

2.

ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.

Madan M, Patel A, Skruber K, Geerts D, Altomare DA, Iv OP.

Am J Cancer Res. 2016 Jun 1;6(6):1231-52. eCollection 2016.

3.

Designing the polyamine pharmacophore: influence of N-substituents on the transport behavior of polyamine conjugates.

Kaur N, Delcros JG, Archer J, Weagraff NZ, Martin B, Phanstiel Iv O.

J Med Chem. 2008 Apr 24;51(8):2551-60. doi: 10.1021/jm701341k. Epub 2008 Mar 26.

PMID:
18363351
4.

Lipopolyamine treatment increases the efficacy of intoxication with saporin and an anticancer saporin conjugate.

Geden SE, Gardner RA, Fabbrini MS, Ohashi M, Phanstiel Iv O, Teter K.

FEBS J. 2007 Sep;274(18):4825-36. Epub 2007 Aug 22.

5.

Defining the molecular requirements for the selective delivery of polyamine conjugates into cells containing active polyamine transporters.

Wang C, Delcros JG, Cannon L, Konate F, Carias H, Biggerstaff J, Gardner RA, Phanstiel IV O 4th.

J Med Chem. 2003 Nov 20;46(24):5129-38.

PMID:
14613316
6.

Synthesis and characterization of N(1)-(4-toluenesulfonyl)-N(1)- (9-anthracenemethyl)triamines.

Wang C, Abboud KA, Phanstiel IV O.

J Org Chem. 2002 Nov 1;67(22):7865-8.

PMID:
12398516
7.

An Improved Synthesis of O-Benzoyl Protected Hydroxamates.

Wang QX, King J, Phanstiel IV O.

J Org Chem. 1997 Nov 14;62(23):8104-8108.

PMID:
11671918

Supplemental Content

Loading ...
Support Center